Expression of PIAS Genes in Migraine Patients

[1]  M. Taheri,et al.  A Comprehensive Review on the Role of Genetic Factors in the Pathogenesis of Migraine , 2021, Journal of Molecular Neuroscience.

[2]  A. Sayad,et al.  Differential Expression of Cytokine-Coding Genes among Migraine Patients with and without Aura and Normal Subjects , 2020, Journal of Molecular Neuroscience.

[3]  L. Edvinsson,et al.  Mechanisms of migraine as a chronic evolutive condition , 2019, The Journal of Headache and Pain.

[4]  M. Taheri,et al.  Protein inhibitor of activated STAT genes are differentially expressed in breast tumor tissues. , 2019, Personalized medicine.

[5]  A. Sayad,et al.  PIAS genes as disease markers in bipolar disorder , 2019, Journal of cellular biochemistry.

[6]  A. Sayad,et al.  Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients , 2018, Journal of inflammation research.

[7]  Ming-Chong Yang,et al.  Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation , 2018, Front. Immunol..

[8]  J. Olesen.  International Classification of Headache Disorders , 2018, The Lancet Neurology.

[9]  Nan Chen,et al.  Valproate Plays a Protective Role against Migraine by Inhibiting Protein Kinase C Signalling in Nitroglycerin‐treated Mice , 2018, Basic & clinical pharmacology & toxicology.

[10]  G. Dussor,et al.  Neurovascular contributions to migraine: Moving beyond vasodilation , 2016, Neuroscience.

[11]  Yan Li,et al.  NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α , 2015, Science Signaling.

[12]  C. Ghelardini,et al.  Inhibition of the PKCγ-ε Pathway Relieves from Meningeal Nociception in an Animal Model: An Innovative Perspective for Migraine Therapy? , 2012, Neurotherapeutics.

[13]  K. Ozato,et al.  PIASy Inhibits Virus-induced and Interferon-stimulated Transcription through Distinct Mechanisms* , 2011, The Journal of Biological Chemistry.

[14]  R. Khalil,et al.  Inflammatory cytokines in vascular dysfunction and vascular disease. , 2009, Biochemical pharmacology.

[15]  A. Hoffmann,et al.  Negative regulation of constitutive NF‐κB and JNK signaling by PKN1‐mediated phosphorylation of TRAF1 , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[16]  E. Tolkunova,et al.  PIAS proteins as repressors of Oct4 function. , 2007, Journal of molecular biology.

[17]  G. Carpino,et al.  An overview on immune system and migraine. , 2007, European review for medical and pharmacological sciences.

[18]  K. Shuai,et al.  Regulation of gene-activation pathways by PIAS proteins in the immune system , 2005, Nature Reviews Immunology.

[19]  D. Chang,et al.  Inhibition of Stat1-mediated gene activation by PIAS1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.